Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
about
Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV InfectionSeroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimationEstimation of the prevalence and rate of acute transfusion reactions occurring in Windhoek, Namibia.Investments in blood safety improve the availability of blood to underserved areas in a sub-Saharan African country.Estimating HIV incidence based on combined prevalence testing.Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors.First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.Hepatitis C genotype distribution in patient and blood donor samples in South Africa for the period 2008-2012.Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?Preanalytical stability of HIV-1 and HCV RNA: impact of storage and plasma separation from cells on blood donation testing by NAT.A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.Blood safety begins with safe donations: update among blood donors in Yaounde, Cameroon.Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis.New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology
P2860
Q27471998-E7570B47-E4B0-4D44-83F8-2EF0476E43B1Q33939067-B580AF04-04F7-416F-B650-6CAF75598AE0Q33953448-AF66201A-E657-45F4-AFBE-18A25FC2E5B9Q36171147-89D56FE6-F60D-4B07-AB93-120D4829FF96Q36253535-D4BFE23F-935D-4352-BCBA-6E88E8DB7724Q36890459-3119D01B-7A03-4789-BC94-6F48749F1864Q38421534-71869BB1-6562-4F9B-AA70-052E6CABDDA5Q38879392-694A1464-BDF8-4CB8-9AE8-A011EEB85B51Q40498701-3694CFFC-C225-4E7D-A9D7-07E7635534DCQ42997289-517D8639-570D-4CCC-B312-65E51294EEBAQ43001633-105B4D51-2614-42FB-9439-C08DBF53A5F2Q44931522-B2D9A0A7-9E42-4BFD-B1D6-F7141AAF04B6Q45362712-BEDFCD89-2F9C-4E41-8CDC-DB70A00DF018Q45399264-D42170D3-2F24-4095-A903-F2BDF17FB136Q46193304-AE1B9DCD-C010-4045-A5D2-7769ACA98780Q46854672-8CE476A8-841E-4FB7-AAE3-7C210A140CCDQ56916502-1679FE43-FA0F-4959-9041-28EA8F099748
P2860
Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Human immunodeficiency virus-1 ...... yield of nucleic acid testing.
@en
Human immunodeficiency virus-1 ...... yield of nucleic acid testing.
@nl
type
label
Human immunodeficiency virus-1 ...... yield of nucleic acid testing.
@en
Human immunodeficiency virus-1 ...... yield of nucleic acid testing.
@nl
prefLabel
Human immunodeficiency virus-1 ...... yield of nucleic acid testing.
@en
Human immunodeficiency virus-1 ...... yield of nucleic acid testing.
@nl
P2093
P2860
P1433
P1476
Human immunodeficiency virus-1 ...... yield of nucleic acid testing.
@en
P2093
P2860
P356
10.1046/J.1423-0410.2003.00311.X
P577
2003-07-01T00:00:00Z